Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

iwCLL 2021 | BCL receptor signalling and CLL cell migration

Dimitar Efremov • 15 Sep 2021
iwCLL 2021
Chronic Lymphocytic Leukemia Leukemia

Dimitar Efremov, MD, PhD, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy, discusses the role of different receptor-ligand systems in regulating cancer cell growth in chronic lymphocytic leukemia (CLL). In-vivo evidence already exists for a pro-cancer role of BCL, toll-like and CXCR4 receptors; however, the relative contribution of each of these receptors to cancer growth remains unclear. Dr Efremov reports new findings that link BCL receptor, macrophage and CXCR4 receptor signalling to the regulation of leukemia cell migration. This interview was conducted during the 2021 virtual international workshop on CLL (iwCLL) congress.

More from Dimitar Efremov

2:02
The efficacy of plerixafor in the treatment of CLL
Dimitar Efremov • 10 Mar 2022
1:11
The role of macrophage signals and CXCR4 in the growth of CLL cells
Dimitar Efremov • 10 Mar 2022
1:25
An insight into the future treatment landscape of CLL
Dimitar Efremov • 10 Mar 2022
1:37
How BCR signaling influences cell proliferation in CLL
Dimitar Efremov • 10 Mar 2022

Related Videos

2:24
Manipulating the gut microbiome to improve outcomes of alloSCT for hematological malignancies
Florent Malard • 11 Apr 2024
2:05
Investigating mutation order in AML using single-cell sequencing
Ravindra Majeti • 8 Apr 2024
3:12
An epitope editing approach to enable the use of targeted immunotherapy in AML
Gabriele Casirati • 9 Apr 2024
0:59
Developing LSC-targeting agents in AML: progress and current therapeutic capacity
Ravindra Majeti • 8 Apr 2024
The content of VJHemOnc is intended for healthcare professionals